256 related articles for article (PubMed ID: 19604460)
1. Clinical update on teriparatide.
File E; Deal C
Curr Rheumatol Rep; 2009 Jul; 11(3):169-76. PubMed ID: 19604460
[TBL] [Abstract][Full Text] [Related]
2. Teriparatide in the treatment of osteoporosis.
Stroup J; Kane MP; Abu-Baker AM
Am J Health Syst Pharm; 2008 Mar; 65(6):532-9. PubMed ID: 18319498
[TBL] [Abstract][Full Text] [Related]
3. Indications to teriparatide treatment in patients with osteoporosis.
Rizzoli R; Kraenzlin M; Krieg MA; Mellinghoff HU; Lamy O; Lippuner K
Swiss Med Wkly; 2011; 141():w13297. PubMed ID: 22057669
[TBL] [Abstract][Full Text] [Related]
4. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
5. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis.
Deal C; Gideon J
Cleve Clin J Med; 2003 Jul; 70(7):585-6, 589-90, 592-4 passim. PubMed ID: 12882381
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone as an anabolic skeletal therapy.
Rubin MR; Bilezikian JP
Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
[TBL] [Abstract][Full Text] [Related]
8. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.
Bilezikian JP
Curr Osteoporos Rep; 2008 Mar; 6(1):24-30. PubMed ID: 18430397
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteoporosis with parathyroid hormone and teriparatide.
Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
[TBL] [Abstract][Full Text] [Related]
10. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
[TBL] [Abstract][Full Text] [Related]
11. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Teriparatide for osteoporosis associated with lifestyle-related diseases].
Fukumoto S
Clin Calcium; 2014 Nov; 24(11):1701-5. PubMed ID: 25355155
[TBL] [Abstract][Full Text] [Related]
12. [The Importance of teriparatide in the treatment of osteoporosis].
Yamauchi M
Clin Calcium; 2016 Jun; 26(6):905-13. PubMed ID: 27230847
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
Skiba K; Adamczak M; Wiecek A
Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
[TBL] [Abstract][Full Text] [Related]
14. Anabolic therapy for osteoporosis: parathyroid hormone.
Cosman F
Curr Osteoporos Rep; 2005 Dec; 3(4):143-9. PubMed ID: 16303114
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic targets for osteoporosis.
Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
[TBL] [Abstract][Full Text] [Related]
16. Anabolic Therapy and Optimal Treatment Sequences for Patients With Osteoporosis at High Risk for Fracture.
Cosman F
Endocr Pract; 2020 Jul; 26(7):777-786. PubMed ID: 33471647
[TBL] [Abstract][Full Text] [Related]
17. The use of parathyroid hormone in the treatment of osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):113-21. PubMed ID: 17043762
[TBL] [Abstract][Full Text] [Related]
18. Sequential therapy in the treatment of osteoporosis.
Boonen S; Milisen K; Gielen E; Vanderschueren D
Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
[TBL] [Abstract][Full Text] [Related]
19. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis.
Lou S; Wang L; Wang Y; Jiang Y; Liu J; Wang Y
Medicine (Baltimore); 2017 Dec; 96(52):e9534. PubMed ID: 29384970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
